Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa. (2023)

First Author: Olupot-Olupot P
Attributed to:  MICA: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2022017051

PubMed Identifier: 36375125

Publication URI: http://europepmc.org/abstract/MED/36375125

Type: Journal Article/Review

Volume: 141

Parent Publication: Blood

Issue: 12

ISSN: 0006-4971